However, the market development is hampered by the high-cost criteria for the safety and health of the GLP-1 agonists market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high GLP-1 agonists because GLP-1 agonists are expensive, which can prevent some patients from getting the treatment they need
Patients with relatively stable blood sugar but persistent overeating may find phentermine particularly helpful
However, oral administration is gaining traction, led by Rybelsus, the first oral GLP-1 approved by the FDA
50% and 57% of participants in the 10-mg and 15-mg groups had a reduction in body weight of 20% or more, as compared with 3% in the placebo group [24]
She has not disclosed which kind
If you have concerns or questions, dont hesitate to reach out to your healthcare team for guidance and support